本页面由Tiger Trade Technology Pte. Ltd.提供服务

BioRestorative Therapies, Inc.

0.2570
-0.0030-1.15%
盘后0.2547-0.0023-0.89%19:47 EDT
成交量:184.15万
成交额:46.75万
市值:654.79万
市盈率:-0.16
高:0.2603
开:0.2603
低:0.2466
收:0.2600
52周最高:2.05
52周最低:0.1900
股本:2,547.82万
流通股本:2,417.53万
量比:1.69
换手率:7.62%
股息:- -
股息率:- -
每股收益(TTM):-1.5837
每股收益(LYR):-1.5837
净资产收益率:-320.47%
总资产收益率:-119.56%
市净率:19.10
市盈率(LYR):-0.16

数据加载中...

2024/03/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

重要事件披露

Form 8-K - Current report
2024/02/05

重要事件披露

Form 8-K - Current report
2024/02/01

重要事件披露

Form 8-K - Current report
2023/11/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/16

重要事件披露

Form 8-K - Current report
2023/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/13

重要事件披露

Form 8-K - Current report
2023/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/14

重要事件披露

8-K - Current report
2023/04/06

重要事件披露

8-K - Current report
2023/03/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/27

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals